Search
Medical Properties Trust Inc
MPWAdd to Watchlist
5.020USD
0.0000.00%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
2.71BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-01-30The current earnings forecast score of Medical Properties Trust Inc is 6.00, ranking 155 out of 192 in the Residential & Commercial REITs industry. The average price target is 5.00, with a high of 6.00 and a low of 4.50.
Analyst Rating
Based on
9
analysts
Hold
Current Rating
5.786
Target Price
+27.72%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
92
Total
8
Median
9
Average
Company name
Ratings
Analysts
Medical Properties Trust Inc
MPW
9
Equinix Inc
EQIX
33
Digital Realty Trust Inc
DLR
33
VICI Properties Inc
VICI
25
American Tower Corp
AMT
25
Gaming and Leisure Properties Inc
GLPI
24
1
2
3
...
19
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Medical Properties Trust Inc's expected revenue for the next quarter?
Medical Properties Trust Inc's expected revenue is 247.84M.
What is Medical Properties Trust Inc's price target?
Analysts forecast that Medical Properties Trust Inc's price target is USD 5.00, with the highest forecast at USD 6.00 and the lowest forecast at USD 4.50.
How have Medical Properties Trust IncMPW's recent earnings per share performed?
The market expectation was USD 0.05, while Medical Properties Trust IncMPW's earnings per share (EPS) for the previous quarter was USD 0.03. EPS for the next quarter is expected at USD 0.01.
What is the analyst rating for Medical Properties Trust Inc?
Based on the ratings of Medical Properties Trust Inc's stock from 9 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.
